Healthcare Product

 
Stock Quotes for Healthcare Product top ^
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Value
  • Stock Type: Distressed
Sign-up for ahpi investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Value
  • Stock Type: Distressed
Sign-up for ahpi investment picks

 
News Articles for Healthcare Product top ^
Evidence at the Association for the Healthcare Environment (AHE) conference underscores the need to eliminate microorganisms from all surfaces in the healthcare environment INDIANAPOLIS , Sept.
Sign-up for Trusted Clorox Healthcare Products Now EPA-Registered to Kill Infection-Causing Pathogens on Hard-to-Treat Soft Surfaces investment picks
ST. LOUIS , Nov.
Sign-up for Allied Healthcare Products Reports Loss On Depressed Sales investment picks
2014/2/13
ST. LOUIS , Feb.
Sign-up for Allied Healthcare Products Reports Second Quarter Loss investment picks
2013/9/27
ST. LOUIS , Sept.
Sign-up for Allied Healthcare Products Reports Loss On Sales Decline investment picks
2014/2/11
With the Medical Device Design & Manufacturing Tradeshow kicking off, Interlink Electronics, Inc. (OTC: LINK), a global leader in sensor and human-machine interface technologies, today released an appropriate and relevant White Paper, " Enhancing Medical Devices and Personal Healthcare Products with Force Sensing Technology". The medical field presents special challenges to equipment manufacturers.
Sign-up for Interlink Electronics Releases Medical White Paper, "Enhancing Medical Devices and Personal Healthcare Products with Force Sensing Technology" investment picks
2014/2/25
NEW YORK, NY, Feb.
Sign-up for Navigators Specialty Expands Professional Liability Division with Allied Healthcare Product investment picks
2014/3/12
BETHESDA, Md., March 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) today announced that Sucampo Pharma Europe, Ltd., its wholly owned subsidiary, has received a notice of refusal to grant a Type II variation for AMITIZA ® (lubiprostone) 24 mcg for opioid- induced constipation (OIC) from the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (U.K.). In 2012, the MHRA approved AMITIZA for the treatment of chronic idiopathic constipation (CIC) and associated symptoms in adults when response to diet and other non-pharmacological measures (e.g., educational measures, physical activity) are inappropriate.
Sign-up for Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K. investment picks
Ultimate Software (Nasdaq: ULTI) , a leading cloud provider of people management solutions, announced today that Octapharma Plasma, a U.S.-based subsidiary of Octapharma AG, one of the world’s largest plasma products manufacturers, is leveraging the UltiPro solution to support rapid expansion, deliver strategic business intelligence to executives and managers, and achieve a range of companywide business benefits.
Sign-up for Healthcare Products Manufacturer Leverages Ultimate Software’s UltiPro for Unified Human Capital Management, Overall Business Efficiencies investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Healthcare Product
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Healthcare Plans  |  Next: Healthcare Professional